NorgrenLHiattWRDormandyJA. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Section F: Revascularization. Eur J Vasc Endovasc Surg.2007; 33(Suppl 1): S54–S64.
2.
DormandyJARutherfordRB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg.2000; 31: S1–S296.
3.
TetterooEvan der GraafYBoschJL. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998; 351: 1153–1159.
4.
KleinWMvan der GraafYSeegersJ. Dutch iliac stent trial: Long-term results in patients randomized for primary or selective stent placement. Radiology. 2006; 238: 734–744.
5.
AdamDJBeardJDClevelandT. Bypass surgery versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet. 2005; 366: 1925–1934.
6.
PonecDJaffMRSwischukJ. The nitinol SMART stent vs. Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol.2004; 15: 911–918.
7.
BoschJLHuninkMG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997; 204: 87–96.
8.
CejnaMTurnherSIlliaschH. PTA versus Palmaz stent in femoropopliteal artery obstructions: A multicenter prospective randomized study. J Vasc Interv Radiol.2001; 12: 23–31.
9.
VroegineweijDVosLDTielbeekAV. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol.1997; 20: 420–425.
10.
GrimmJMüller-HülsbeckSJahnkeT. Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol.2001; 12: 935–942.
11.
ZdanowskiZAlbrechtssonULundinA. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol.1999; 18: 251–255.
12.
BecqueminJPFavreJPMarzelleJ. Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomised study. J Vasc Surg.2003; 37: 487–494.
13.
DudaSHPusichBRichterG. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-months results. Circulation. 2002; 106: 1505–1509.
14.
SchillingerMSabetiSLoeweC. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med.2006; 354: 1879–1888.
15.
KrankenbergHfor the FAST Investigators. Femoral artery stenting trial–12-month final analysis. Presented at Transcatheter Cardiovascular Therapies; October 22–27, 2006; Washington, DC, USA.
16.
DudaSHBosiersMLammerJ. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther.2006; 13: 701–710.
17.
SchillingerMMlekuschWHaumerM. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther.2003; 10: 288–297.
